JP2005532318A5 - - Google Patents

Download PDF

Info

Publication number
JP2005532318A5
JP2005532318A5 JP2004503446A JP2004503446A JP2005532318A5 JP 2005532318 A5 JP2005532318 A5 JP 2005532318A5 JP 2004503446 A JP2004503446 A JP 2004503446A JP 2004503446 A JP2004503446 A JP 2004503446A JP 2005532318 A5 JP2005532318 A5 JP 2005532318A5
Authority
JP
Japan
Prior art keywords
methyl
alkyl
tetrahydro
disorder
benzenesulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004503446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005532318A (ja
Filing date
Publication date
Priority claimed from GBGB0210762.1A external-priority patent/GB0210762D0/en
Application filed filed Critical
Publication of JP2005532318A publication Critical patent/JP2005532318A/ja
Publication of JP2005532318A5 publication Critical patent/JP2005532318A5/ja
Pending legal-status Critical Current

Links

JP2004503446A 2002-05-10 2003-05-09 抗精神病薬としてのドーパミン受容体モジュレーター Pending JP2005532318A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0210762.1A GB0210762D0 (en) 2002-05-10 2002-05-10 Compounds
PCT/GB2003/001983 WO2003095428A1 (en) 2002-05-10 2003-05-09 Dopamine receptor modulators as antipsychotic agents

Publications (2)

Publication Number Publication Date
JP2005532318A JP2005532318A (ja) 2005-10-27
JP2005532318A5 true JP2005532318A5 (cg-RX-API-DMAC7.html) 2006-06-29

Family

ID=9936447

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004503446A Pending JP2005532318A (ja) 2002-05-10 2003-05-09 抗精神病薬としてのドーパミン受容体モジュレーター

Country Status (6)

Country Link
US (1) US20070043026A1 (cg-RX-API-DMAC7.html)
EP (1) EP1503989A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005532318A (cg-RX-API-DMAC7.html)
AU (1) AU2003227919A1 (cg-RX-API-DMAC7.html)
GB (1) GB0210762D0 (cg-RX-API-DMAC7.html)
WO (1) WO2003095428A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY133587A (en) 2002-05-29 2007-11-30 Glaxo Group Ltd Aromatic sulfones and their medical use
GB0329214D0 (en) * 2003-12-17 2004-01-21 Glaxo Group Ltd Novel compounds
US20050137186A1 (en) * 2003-12-18 2005-06-23 Abbott Gmbh & Co. Kg. Tetrahydrobenzazepines and their use
US8207160B2 (en) 2003-12-18 2012-06-26 Abbott Gmbh & Co. Kg Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor
TW200611701A (en) * 2004-06-18 2006-04-16 Glaxo Group Ltd Novel compounds
EP2371814A1 (en) * 2004-10-14 2011-10-05 Abbott GmbH & Co. KG Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
EP1837332A1 (en) * 2006-03-23 2007-09-26 Laboratorios Del Dr. Esteve, S.A. Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
US7897595B2 (en) 2006-05-26 2011-03-01 Forest Laboratories Holdings Limited Pyridoazepine derivatives
US8258134B2 (en) * 2008-04-16 2012-09-04 Hoffmann-La Roche Inc. Pyridazinone glucokinase activators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321254A (en) * 1980-09-26 1982-03-23 Smithkline Corporation Antiallergic imidodisulfamides
US5112824A (en) * 1989-12-08 1992-05-12 Merck & Co., Inc. Benzofuran compounds as class III antiarrhythmic agents
US5684195A (en) * 1994-07-14 1997-11-04 G. D. Searle & Co. Method of preparing sulfmonamides from sulfones
NZ332757A (en) * 1996-06-17 1999-06-29 Smithkline Beecham Plc Substituted tetrahydroisoquinoline benzamide derivatives and their use as anticonvulsants and psycho-active agents
IL131756A0 (en) * 1997-03-18 2001-03-19 Smithkline Beecham Plc Substituted isoquinoline derivatives and their use as anticonvulsants
JP2001521026A (ja) * 1997-10-24 2001-11-06 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 置換イソキノリン誘導体および抗痙攣薬としての使用
DE10053799A1 (de) * 2000-10-30 2002-05-08 Bayer Ag Verwendung von Tetrahydroisochinolinsulfonamiden

Similar Documents

Publication Publication Date Title
JP2005518414A5 (cg-RX-API-DMAC7.html)
CN1131212C (zh) 苯基-和吡啶基衍生物
HUP0300350A2 (hu) Új 3-amino-azetidin-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
JP2005526723A5 (cg-RX-API-DMAC7.html)
JP2006519258A5 (cg-RX-API-DMAC7.html)
JP2004509162A (ja) アミノアルコール誘導体
JP2012502986A5 (cg-RX-API-DMAC7.html)
MXPA05000196A (es) Derivados de 1-amido-4-fenil-4-benciloximetil-piperidina y compuestos relacionados como antagonistas de neurocinina-1(nk-1)para el tratamiento de vomito, depresion, ansiedad y tos.
RU2009138219A (ru) Новые бензамидные производные и способ их получения
RU2008127501A (ru) Сульфонилзамещенные 1н-индолы в качастве лигандов 5-гидрокситриптаминовых рецепторов
RU2001130169A (ru) Производные карбаминовой кислоты и их применение в качестве лигандов метаботропных глутаматных рецепторов
CA2702933A1 (en) Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
JP2005513016A5 (cg-RX-API-DMAC7.html)
RU2006105777A (ru) Индол-6-ильные сульфонамидные производные, их получение и их применение в качестве модуляторов 5-нт-6
CA2529126A1 (en) Azetidine compounds
RU2006105779A (ru) Индол-5-ильные сульфонамидные производные, их получение и их применение в качестве модуляторов 5-нт-6
JP2008542365A5 (cg-RX-API-DMAC7.html)
WO2010040274A1 (zh) 新型多巴胺d3受体配体,其制备方法及其医药用途
JP2006525297A5 (cg-RX-API-DMAC7.html)
JP2006519812A (ja) フェニルスルホン誘導体およびcns障害の治療におけるその使用
RU2156250C2 (ru) Производные хромона, способ их получения и фармацевтическая композиция
TWI423967B (zh) 醯胺衍生物及含有其之醫藥組合物
CN1063177C (zh) 治疗偏头痛的吲哚烷基-吡啶基和嘧啶基哌嗪的1,2,5-噻二唑衍生物
CN105916850A (zh) 作为激酶抑制剂的取代的二烷基(氧撑)-λ4-硫烷亚基烟酰胺衍生物
CN101160295A (zh) 3,4-二氢-苯并[e][1,3]嗪-2-酮类化合物